Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes.

Mariani SA, Vicenzi E, Poli G.

J Transl Med. 2011 Jan 27;9 Suppl 1:S8. doi: 10.1186/1479-5876-9-S1-S8. Review.

2.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
3.

Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.

Stantchev TS, Broder CC.

Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):219-43. Review. Erratum in: Cytokine Growth Factor Rev 2001 Dec;12(4):395-8.

PMID:
11325604
4.

Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.

Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

J Transl Med. 2011 Jan 27;9 Suppl 1:S1. doi: 10.1186/1479-5876-9-S1-S1. Review.

5.

The puzzling role of CXCR4 in human immunodeficiency virus infection.

Vicenzi E, LiĆ² P, Poli G.

Theranostics. 2013;3(1):18-25. doi: 10.7150/thno.5392. Epub 2013 Jan 13. Review.

6.

An intricate Web: chemokine receptors, HIV-1 and hematopoiesis.

Lee B, Doranz BJ, Ratajczak MZ, Doms RW.

Stem Cells. 1998;16(2):79-88. Review.

7.

HIV and the chemokine system: 10 years later.

Lusso P.

EMBO J. 2006 Feb 8;25(3):447-56. Epub 2006 Jan 26. Review.

8.

[Chemokine receptors and HIV-1 infection].

Hieshima K, Yoshie O.

Nihon Rinsho. 2002 Apr;60(4):681-7. Review. Japanese.

PMID:
11968773
9.

[Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].

Azevedo-Pereira JM, Santos-Costa Q.

Acta Med Port. 2008 Sep-Oct;21(5):497-504. Epub 2009 Jan 16. Review. Portuguese.

10.

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV.

Cicala C, Arthos J, Fauci AS.

J Transl Med. 2011 Jan 27;9 Suppl 1:S2. doi: 10.1186/1479-5876-9-S1-S2. Review.

11.

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.

Seibert C, Sakmar TP.

Curr Pharm Des. 2004;10(17):2041-62. Review.

PMID:
15279544
12.

R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies.

Loftin LM, Kienzle M, Yi Y, Collman RG.

J Transl Med. 2011 Jan 27;9 Suppl 1:S3. doi: 10.1186/1479-5876-9-S1-S3. Review.

13.

Coreceptor use in nonhuman primate models of HIV infection.

Sina ST, Ren W, Cheng-Mayer C.

J Transl Med. 2011 Jan 27;9 Suppl 1:S7. doi: 10.1186/1479-5876-9-S1-S7. Review.

14.

HIV: cell binding and entry.

Wilen CB, Tilton JC, Doms RW.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a006866. doi: 10.1101/cshperspect.a006866. Review.

15.

HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages.

Freedman BD, Liu QH, Del Corno M, Collman RG.

Immunol Res. 2003;27(2-3):261-76. Review.

PMID:
12857973
16.

Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Choi WT, An J.

Exp Biol Med (Maywood). 2011 Jun 1;236(6):637-47. doi: 10.1258/ebm.2011.010389. Epub 2011 May 12. Review.

17.

The molecular basis of HIV entry.

Klasse PJ.

Cell Microbiol. 2012 Aug;14(8):1183-92. doi: 10.1111/j.1462-5822.2012.01812.x. Epub 2012 Jun 5. Review.

18.

Plasma membrane signaling in HIV-1 infection.

Abbas W, Herbein G.

Biochim Biophys Acta. 2014 Apr;1838(4):1132-42. doi: 10.1016/j.bbamem.2013.06.020. Epub 2013 Jun 24. Review.

19.

[Role of chemokine receptors in T lymphocytes].

Utsunomiya I.

Seikagaku. 1998 Oct;70(10):1266-70. Review. Japanese. No abstract available.

PMID:
9847694

Supplemental Content

Support Center